Change search
ReferencesLink to record
Permanent link

Direct link
Clinical effects of the heparin coated surface in cardiopulmonary bypass
Umeå University, Faculty of Medicine, Department of Surgical and Perioperative Sciences.
Show others and affiliations
1997 (English)In: European Journal of Cardio-Thoracic Surgery, ISSN 1010-7940, E-ISSN 1873-734X, Vol. 11, no 5, 957-964 p.Article in journal (Refereed) Published
Abstract [en]

OBJECTIVE: In a randomised study of 120 patients, undergoing primary operation for coronary heart decease, two groups were investigated as regards to the effects of heparin coated cardiopulmonary bypass on brainfunction parameters and general clinical outcome. The study group (n = 56) was perfused using an extra-corporeal circuit treated with covalent bonded heparin; the control group (n = 59) used an identical set-up without heparin treatment. Systemic heparin doses were calculated to achieve ACT levels of 250 and 500 s, respectively. Postoperative course was evaluatedby examining a set of clinically relevant parameters including a detailed registry of postoperative deviations. Brain function was assessed by the biochemical marker S-100 and tests of memory performance.

RESULTS: There were several signs of reduced operative trauma in the study group. Hospital stay was reduced by nearly 1 day (P < 0.05). Time on postoperative ventilatory support was approximately 4 h shorter (P = 0.009). Chest drain blood loss was decreased both at 8 (P = 0.01) and 24 h (P = 0.007) postoperatively. Body temperature was lower after surgery and especially on days 2 (P = 0.03) and 3 (P = 0.01). Perioperative creatinine elevation was significantly reduced (P = 0.03). Neurological deviations were fewer (P =0.01). Brain function assessment revealed reduced plasma levels of S- 100 both at termination of cardiopulmonary bypass (P = 0.008) and 7 h later (P= 0.04). However, no remediation of memory impairment could be demonstrated.

CONCLUSIONS: Cardiopulmonary bypass with covalent bonded heparin attached to the extra-corporeal circuit in combination with a reduced systemic heparin dose seems to reduce safely and effectively the operative stress to the patient. There were also signs of improved cerebral protection.

Place, publisher, year, edition, pages
Oxford University Press, 1997. Vol. 11, no 5, 957-964 p.
Keyword [en]
cardiopulmonary bypass, heparin, biocompatible materials, thoracic surgery, memory, nerve tissue protein S-100
National Category
Cardiac and Cardiovascular Systems Surgery
URN: urn:nbn:se:umu:diva-2524DOI: 10.1016/S1010-7940(97)88351-0ISI: A1997XE01800042OAI: diva2:140695
Available from: 2003-10-22 Created: 2003-10-22 Last updated: 2015-08-31Bibliographically approved
In thesis
1. Heparin coating and cardiotomy suction in cardiopulmonary bypass
Open this publication in new window or tab >>Heparin coating and cardiotomy suction in cardiopulmonary bypass
2003 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

The present thesis addresses various means of reducing inflammatory responses associated with cardiopulmonary bypass (CPB) and retransfusion of pericardial suction blood (PSB) during cardiac surgery.

Four (I-IV) prospective randomised controlled clinical trials comprising 475 patients were performed in the following areas: effects of heparin coating on measures of clinical outcome and memory function (I, II), inflammatory reactions in PSB and its systemic effects after retransfusion using cardiotomy suction or cell salvage (III) and effects of retransfusion of PSB on memory function and release patterns of protein S100B (IV).

The use of heparin coated CPB-circuits was associated with a decrease of postoperative blood loss (I, II), transfusion requirements (II), shorter stay in hospital (I) decreased postoperative ventilator time (I), lower incidences of atrial fibrillation (II) and neurological deviations (I), reduction in releases of protein S100B (I, II) and lower postoperative creatinine elevation (I, II).

PSB contained high concentrations of cytokines, complements, myeloperoxidase, free plasma haemoglobin and protein S100B (III, IV). Retransfusion using cardiotomy suction increased the systemic concentrations of free plasma haemoglobin and protein S100B, whereas retransfusion using cell salvage caused no detectable systemic effects (III, IV). CPB was associated with a small but significant release of protein S100B, despite elimination of PSB-contained protein S100B using cell salvage (IV).

Subtle signs of impaired memory function were identified that were not associated with the use of heparin coated CPB-circuits (I, II) or retransfusion of PSB (IV).

Key words: cardiopulmonary bypass, oxygenators, heparin, S100 proteins, blood loss, haemostasis, memory, outcome and process assessment.

71 p.
Umeå University medical dissertations, ISSN 0346-6612 ; 855
Surgery, cardiopulmonary bypass, oxygenators, heparin, S100 proteins, blood loss, haemostasis, memory, outcome and process assessment, Kirurgi
National Category
Research subject
urn:nbn:se:umu:diva-134 (URN)91-7305-523-9 (ISBN)
Public defence
2003-11-21, Aulan, Administrationsbyggnaden, Norrlands Universitetssjukhus, Umeå, 13:00
Available from: 2003-10-22 Created: 2003-10-22 Last updated: 2012-06-28Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Svenmarker, Staffan
By organisation
Department of Surgical and Perioperative Sciences
In the same journal
European Journal of Cardio-Thoracic Surgery
Cardiac and Cardiovascular SystemsSurgery

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 20 hits
ReferencesLink to record
Permanent link

Direct link